Our trials and initiatives
Funding innovative treatments, supporting clinical trials, and delivering more advanced health care and medical technology to improve the health of all Australians.
Emerging Priorities and Consumer Driven Research
The Emerging Priorities and Consumer Driven Research initiative provides $633 million over 10 years from 2019–20 and supports high-quality research that improves patient care, translates new discoveries into practice, and encourages consumers and researchers to work together on emerging priorities.
This initiative will:
- improve patient care
- translate new discoveries into clinical practice
- encourage researchers to work together with the public on projects that matter to the public
- connect researchers to consumers, carers and clinicians and foster partnerships
This initiative includes projects previously covered under the Accelerated Research initiative.
To find out key information at a glance, access this initiative's MRFF snapshot.
Rare Cancers, Rare Diseases and Unmet Need Clinical Trials
The Rare Cancers, Rare Diseases and Unmet Need Clinical Trials are funded Australian clinical trials investigating new drugs, devices or treatments for rare diseases or for areas of unmet medical need – this research activity continues as part of the Clinical Trials Activity initiative.
To find out key information at a glance, access this initiative's MRFF snapshot.
Global Health
The Global Health initiative will invest $28.4 million over 10 years to fund projects that improve our understanding of global health threats and how best to tackle them. The initial focus is on tackling antimicrobial resistance and drug-resistant tuberculosis.
Global Health incorporates the following MRFF initiatives:
- National Security Against Pandemic Risk (now completed)
- Tackling Antimicrobial Resistance in Aged Care Facilities
This initiative will also fund new projects in the future.
To find out key information at a glance, access this initiative's MRFF snapshot.